S. U. Berlangieri
Ludwig Institute for Cancer Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by S. U. Berlangieri.
Molecular Imaging and Biology | 2008
Sze Ting Lee; T. Tan; Aurora Poon; H. B. Toh; S. Gill; S. U. Berlangieri; E. Kraft; Amanda J. Byrne; Kunthi Pathmaraj; G. J. O’Keefe; Niall C. Tebbutt; Andrew M. Scott
PurposeTo assess the contribution of concurrent low-dose, noncontrast CT in the assessment of the malignant potential of incidental focal 2-deoxy-2-[F-18]fluoro-d-glucose (FDG)-avid colonic lesions on positron emission tomography/computed tomography (PET/CT).ProceduresRoutine FDG-PET/CT scans were reviewed for identification of focal FDG-avid colon lesions, and the CT component was independently reviewed for an anatomical lesion and malignant potential based on CT criteria. Clinical, endoscopic, and histopathology follow-up was obtained.ResultsA total of 85/2,916 (3%) oncology FDG-PET/CT scans had incidental focal colon lesions. Clinical and/or endoscopic follow-up was available in 83/85 (98%) patients. Focal, corresponding CT lesions were found in 44/83 (53%) patients, but features of malignancy were not assessable. Of the 44 patients with a final diagnosis, 32/44 (73%) were FDG-PET/CT true positives; 5/44 (11%) were false positives; and 7/44 (16%) had inconclusive FDG-PET/CT findings.ConclusionsConcurrent low-dose, noncontrast CT improves localization, but does not provide independent information on the malignant potential of incidental focal colonic activity on FDG-PET/CT.
Internal Medicine Journal | 2007
Sze-Ting Lee; S. U. Berlangieri; Aurora Poon; Paul Mitchell; K. Pathmaraj; K. Tabone; A. J. Byrne; G. J. O’Keefe; S. R. Knight; Clarke Cp; Andrew M. Scott
Background: Accurate staging of lung cancer is essential in determining the most appropriate management plan, as detection of occult metastasis can significantly alter management.
Clinical Nuclear Medicine | 1999
Pointon O; Andrew M. Scott; S. U. Berlangieri; McKay Wj; Goldstein D
A 32-year-old patient with AIDS was examined by Ga-67 citrate and F-18 FDG PET to stage biopsy-proved gastric non-Hodgkins lymphoma. The Ga-67 scan showed increased uptake in the stomach, lungs, and pericardium. The PET study was consistent with lymphomatous involvement in the stomach and lung apices, but no abnormality was evident in the pericardium. The pericardium was not examined by biopsy given the absence of significant symptoms and no large pericardial effusion. The disparity between the Ga-67 and the FDG findings in this region suggested an inflammatory process rather than lymphomatous involvement and highlights the multiple diseases encountered in patients with AIDS.
Journal of Nuclear Medicine Technology | 2005
Fiona O. Roberts; Dishan H. Gunawardana; Kunthi Pathmaraj; Anthony Wallace; Paul L. U; Tian Mi; S. U. Berlangieri; Graeme O’Keefe; Christopher C. Rowe; Andrew M. Scott
Molecular Imaging and Biology | 2009
Sze Ting Lee; M. Ghanem; Rebecca A. Herbertson; S. U. Berlangieri; Amanda J. Byrne; K. Tabone; Paul Mitchell; Simon R. Knight; M. Feigen; Andrew M. Scott
Australasian Physical & Engineering Sciences in Medicine | 1999
Henri Tochon-Danguy; John Sachinidis; Gary F. Egan; Chan Jg; S. U. Berlangieri; McKay Wj; Andrew M. Scott
The Medical Journal of Australia | 1998
Thomas Dm; Paul Mitchell; S. U. Berlangieri; Henri Tochon-Danguy; Simon R. Knight; Clarke Cp; Andrew M. Scott
Annals Academy of Medicine Singapore | 2013
Gerald Jit Shen Tan; Sze-Ting Lee; S. U. Berlangieri; Andrew M. Scott
Molecular Imaging and Biology | 2009
Sze Ting Lee; M. Ghanem; Rebecca A. Herbertson; S. U. Berlangieri; Amanda J. Byrne; K. Tabone; Paul Mitchell; Simon R. Knight; M. Feigen; Andrew M. Scott
Molecular Imaging and Biology | 2009
Sze-Ting Lee; M. Ghanem; Rebecca A. Herbertson; S. U. Berlangieri; Amanda J. Byrne; K. Tabone; Paul Mitchell; Simon R. Knight; M. Feigen; Andrew M. Scott